Clinical Trial Update: Cabozantinib in Advanced Solid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of cabozantinib in advanced solid malignancies completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Solid Tumor

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Lung Cancer, Solid Tumor (Not Breast or Prostate Cancers) | Phase 2 | Status: COMPLETED | Results posted: 2018-01-10